Passage Bio Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 2018-01-01
- Employees
- 101
- Market Cap
- $45.8M
- Website
- http://www.passagebio.com
Study of Safety, Tolerability and Efficacy of PBKR03 in Pediatric Subjects With Early Infantile Krabbe Disease
Phase 1
Suspended
- Conditions
- Leukodystrophy, Globoid Cell
- Interventions
- Biological: PBKR03
- First Posted Date
- 2021-02-25
- Last Posted Date
- 2024-01-18
- Lead Sponsor
- Passage Bio, Inc.
- Target Recruit Count
- 24
- Registration Number
- NCT04771416
- Locations
- 🇨🇦
Montreal Children's Hospital, Montréal, Canada
🇬🇧Manchester University, Manchester, United Kingdom
🇺🇸New York-Presbyterian, New York, New York, United States
A Study of PBFT02 in Participants With FTD and Mutations in the Granulin Precursor (GRN) or C9ORF72 Genes
Phase 1
Recruiting
- Conditions
- Frontotemporal DementiaFTDFTD-GRNDementia FrontotemporalC9orf72
- Interventions
- First Posted Date
- 2021-02-10
- Last Posted Date
- 2025-01-24
- Lead Sponsor
- Passage Bio, Inc.
- Target Recruit Count
- 25
- Registration Number
- NCT04747431
- Locations
- 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States
🇺🇸University of Texas at Houston, Houston, Texas, United States
🇧🇷Hospital das Clinicas da Universidade Federal de Minas Gerais (UFMG), Minas Gerais, Brazil
Study of Safety, Tolerability and Efficacy of PBGM01 in Pediatric Participants With GM1 Gangliosidosis
Phase 1
Active, not recruiting
- Conditions
- Beta-Galactosidase-1 (GLB1) DeficiencyGM1 Gangliosidosis, Type IGM1 Gangliosidosis, Type 2GM1 Gangliosidosis
- Interventions
- First Posted Date
- 2021-01-19
- Last Posted Date
- 2025-05-21
- Lead Sponsor
- Gemma Biotherapeutics
- Target Recruit Count
- 26
- Registration Number
- NCT04713475
- Locations
- 🇺🇸
Benioff Children's Hospital, Oakland, California, United States
🇧🇷Hospital de Clínicas de Porto Alegre (HCPA), Porto Alegre, Brazil
🇬🇧Great Ormond Street Hospital, London, United Kingdom
© Copyright 2025. All Rights Reserved by MedPath